A seed round funds the search for product-market fit, and a Series A funds the scale-up of an engine that already works. Put seed vs Series A side by side and the whole shape of the raise changes: who signs the check, what legal instrument carries the money, and what the company has to have proved before anyone signs it. Read the stage correctly and the paperwork is routine. Read it wrong and you spend four months in diligence for a term sheet that was never coming.
Who writes the check
Seed money comes from angels writing personal checks, from seed-stage funds whose whole portfolio is companies at this point, and from accelerators that invest on standard terms with no negotiation. The relationship is loose. Nobody takes a board seat, the reporting is an email every month or two, and a fund that leads your seed may hold twenty other companies at the same stage.
Series A capital comes from firms that lead priced rounds. One partner owns the deal, sits on your board, and has to defend the investment to an investment committee that will ask about net revenue retention and sales payback. That partner will do reference calls with your customers and your former colleagues.
In the United States, angels usually clear the SEC's accredited investor test. The supportive former manager who wants to put in ten thousand often does not, and that is a conversation to have before the money moves.
The instrument changes from a SAFE to preferred stock
A seed round is usually carried by a convertible instrument. No valuation is negotiated, no charter is amended, and the round can close in pieces as each investor signs. A SAFE can be capped, giving the investor a ceiling valuation at which it converts, or uncapped, in which case a most favored nation clause pulls the best term anyone negotiates later back to everyone who signed earlier. Either form converts into preferred stock once a priced round sets a valuation, and until that round closes nobody on the cap table owns a percentage, only a right to receive one.
Series A is a priced equity financing and the document set changes completely. The company issues preferred stock with a liquidation preference and protective provisions, amends its certificate of incorporation, signs an investors' rights agreement, and gives up a board seat. Every outstanding SAFE and note converts at that moment, which is when the arithmetic from the seed round finally becomes visible on one page.
That conversion is where founders get surprised. Four SAFEs signed eighteen months apart each felt like a deferred decision. They land together, alongside a refreshed option pool that comes out of the pre-money valuation, so the founder ownership after a Series A is often several points below what the term sheet's headline number suggested. Model the fully diluted cap table before the negotiation starts. The pre-seed valuation numbers you accepted early are the input to that model.
The evidence each round is funded on
A seed round is funded on evidence that a real problem exists and that you can build against it. By the end of the round a company should be able to name the customer, the problem, the price, and one repeatable way of finding the next customer. Investors will accept small numbers here as long as the shape is right.
A Series A is funded on evidence that an engine works and is throttled only by capital. The diligence goes to cohort retention, gross margin, net revenue retention, and how long it takes for a sales hire to pay for themselves. Logos on a slide do not survive that read. A cohort chart where month twelve sits above month three does.
The gap between the two is longer than most plans assume, and underestimating it is an expensive planning error at seed. Companies that raise a seed with twelve months of runway and a Series A milestone that needs eighteen months of building end up raising a bridge on worse terms. The seed to Series A gap is worth modelling against your own burn before you set the ask.
The US exemption behind the round
For a US company, the exemption it raises under decides whether the founders can talk about the raise in public, and the two common ones behave differently.
Under Rule 506(b), a company can raise an unlimited amount but may not sell to more than 35 non-accredited investors, and may not use general solicitation or advertising to market the securities. A tweet announcing that you are raising, a public demo day livestream, or a pitch competition can all count as solicitation.
Rule 506(c) permits broad solicitation and general advertising on two conditions: every purchaser is an accredited investor, and the issuer takes reasonable steps to verify that status beyond a self-certification checkbox. Either way a Form D notice goes to the Commission within 15 days after the first sale. Founders who intend to raise loudly should structure the round under 506(c) from the start and budget for the verification work, because an exemption cannot be repaired after the fact.
The deck is a different document at each stage
A seed deck sells a thesis about a market and a team credible enough to chase it. A Series A deck sells a set of numbers and an argument about what more money does to them. The temptation at seed is to borrow the later format, filling slides with cohort charts built on forty customers, which reads as a company overstating what it knows. That is the pattern behind pitch deck inflation.
Where the step from one to the other breaks
The failure here is a seed round sized to the milestone the founder wanted. That milestone is rarely the one the next investor will underwrite.
Work backwards instead. Write down the three metrics a Series A lead in your category will ask for, put a number and a date on each, add the months of building those numbers need, add four months for the raise itself, and size the seed round to cover that with margin. If the answer is bigger than the seed round you can plausibly close, cut the milestone rather than the runway.
Enjoyed this article? Share it.
